How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Non-invasive Ventilation (NIV) Masks Market
- By Product Type: Nasal Masks, Full Face Masks, Nasal Pillows, Oronasal Masks, Hybrid Masks
- By Material Type: Silicone, Gel, Foam, Thermoplastic Elastomer (TPE)
- By Application: Sleep Apnea Therapy, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Failure, Neuromuscular Disorders
- By Age Group: Pediatric, Adult, Geriatric
- By Interface Design: Standard Cushion, Gel Cushion, Memory Foam Cushion, Minimal Contact Design
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Nasal Masks leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Non-invasive Ventilation (NIV) Masks Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material Type 4
Application 4
Age Group 3
Interface Design 4
Companies profiled
ResMed Inc.
Philips Respironics (Royal Philips)
Fisher & Paykel Healthcare Corporation Limited
Drägerwerk AG & Co. KGaA
Medtronic plc
BMC Medical Co. Ltd.
DeVilbiss Healthcare LLC
Vyaire Medical Inc.
Curative Medical Inc.
Somnetics International Inc.
Intersurgical Ltd.
Apex Medical Corp.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →ResMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Philips Respironics (Royal Philips)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Fisher & Paykel Healthcare Corporation Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Drägerwerk AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BMC Medical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →DeVilbiss Healthcare LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Vyaire Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Curative Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Somnetics International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Intersurgical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Apex Medical Corp.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →ZOLL Medical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Invacare Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Nihon Kohden Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,770M by 2033 · 4.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Nasal Masks53.0
- Full Face Masks13.8
- Nasal Pillows6.3
- Oronasal Masks15.6
- Hybrid Masks11.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,090M → $1,481M · 3.9%
Europe$760.0M → $1,152M · 5.3%
Asia Pacific$693.9M → $946.4M · 4.0%
Latin America$429.6M → $670.9M · 5.7%
Middle East and Africa$330.4M → $426.0M · 3.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.652026
4.662027
4.662028
4.692029
4.692030
4.722031
4.722032
4.722033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- ResMed Inc.30.1
- Philips Respironics (Royal Philips)10.3
- Fisher & Paykel Healthcare Corporation Limited10.4
- Drägerwerk AG & Co. KGaA6.2
- Medtronic plc7.3
- BMC Medical Co. Ltd.7.6
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type25.1%
Material Type24.9%
Application12.6%
Age Group27.2%
Interface Design10.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.7
- Europe24.6
- Asia Pacific20.2
- Latin America14.3
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| ResMed Inc. | 87 | 74 | 83 | 96 | 87 | 74 | 84 |
| Philips Respironics (Royal Philips) | 70 | 73 | 91 | 80 | 90 | 85 | 82 |
| Fisher & Paykel Healthcare Corporation Limited | 71 | 67 | 78 | 66 | 76 | 71 | 72 |
| Drägerwerk AG & Co. KGaA | 73 | 67 | 74 | 80 | 73 | 59 | 71 |
| Medtronic plc | 53 | 63 | 67 | 74 | 52 | 69 | 63 |
| BMC Medical Co. Ltd. | 47 | 64 | 63 | 68 | 67 | 51 | 60 |
| DeVilbiss Healthcare LLC | 50 | 54 | 59 | 62 | 66 | 63 | 59 |
| Vyaire Medical Inc. | 43 | 38 | 55 | 54 | 41 | 38 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- ResMed Inc.
- Philips Respironics (Royal Philips)
- Fisher & Paykel Healthcare Corporation Limited
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| ResMed Inc. | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Philips Respironics (Royal Philips) | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Fisher & Paykel Healthcare Corporation Limited | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Drägerwerk AG & Co. KGaA | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Medtronic plc | ◐ | ◐ | ✓ | ◐ | − | ✓ |
| BMC Medical Co. Ltd. | − | ◐ | ◐ | ✓ | − | ◐ |
| DeVilbiss Healthcare LLC | ◐ | − | − | ◐ | − | ◐ |
| Vyaire Medical Inc. | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1ResMed Inc.84
2Philips Respironics (Royal Philips)82
3Fisher & Paykel Healthcare Corporation Limited72
4Drägerwerk AG & Co. KGaA71
5Medtronic plc63
6BMC Medical Co. Ltd.60
7DeVilbiss Healthcare LLC59
8Vyaire Medical Inc.45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
ResMed Inc.Philips Respironics (Royal Philips)
Challenger2
Strong scale, closing on the leaders.
Fisher & Paykel Healthcare Corporation LimitedDrägerwerk AG & Co. KGaA
Contender3
Focused players with pockets of strength.
Medtronic plcBMC Medical Co. Ltd.DeVilbiss Healthcare LLC
Niche1
Specialists in a single segment or region.
Vyaire Medical Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Non-invasive Ventilation (NIV) Masks Market — a $122M beachhead inside a $1.86B market.
Beachhead (SOM)$122Mobtainable near-term
Serviceable (SAM)$742Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Nasal Masks
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Full Face Masks
Strong fit — clear ROI and a fast path to value.
End user67 fit
Nasal Pillows
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Non-invasive Ventilation (NIV) Masks Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified23%
Evaluation14%
Closed-won8%
$13.1KCAC
$61KLTV
4.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Non-invasive Ventilation (NIV) Masks Market is a durable-growth opportunity — $8.61B by 2033, compounding at 8.6%.
TAM · 2025$4.44Btoday
TAM · 2033$8.61Bforecast
CAGR8.6%2027–2033
Cumulative$56.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.61BTotal addressable market
SAM$3.14BServiceable available market
SOM$523MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.61BLarge & growingTAM by 2033 at 8.6% CAGR
$3.14BServiceable nowreachable with today’s model
$523MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.71BBear5.6% CAGR
$8.61BBase8.6% CAGR
$11.0BBull11.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Non-invasive Ventilation (NIV) Masks Market — a $10.2B market by 2033. Plan: grow share from 8.0% to 12.3%.
Market size · 2033$10.2Btotal addressable
Market CAGR9.7%2027–2033
Target share12.3%from 8.0% today
Revenue ambition$1.26Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 12.3% | On track |
| Revenue | $896M | $1.26B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 34.6% | 44.0% | Ahead |
| Customer retention | 85.9% | 93.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material Type capability
A defensible second engine — invest in Material Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $152M capacity & capability investment
- Greenlight bolt-on M&A in Material Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Non-invasive Ventilation (NIV) Masks Market conversation — a $6.16B market you can size, segment and defend in minutes.
Market size · 2033$6.16Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers1,287+accounts in scope
Typical ROI7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7×return on cost, year one
< 4 mopayback period
$93K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
ResMed Inc.Philips Respironics (Royal Philips)Fisher & Paykel Healthcare Corporation LimitedDrägerwerk AG & Co. KGaAMedtronic plcBMC Medical Co. Ltd.DeVilbiss Healthcare LLCVyaire Medical Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Non-invasive Ventilation (NIV) Masks Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Non-invasive Ventilation (NIV) Masks Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Non-invasive Ventilation Masks and Circuits Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportNon-invasive Ventilation Devices Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportNon-Invasive Vagus Nerve Stimulation Device Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportNon-invasive Vaccine Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportNoninvasive Vaccination Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportNon-Invasive Traumatic Brain Injury Monitoring Equipment Market
Market size, share, segmentation and regional forecast.
$309M market · 2025 base year
View reportNoninvasive Temperature Management System Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportNon Invasive Surgery Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportNon-Invasive Sleep Respirator Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportNon-invasive Skin Tightening Device Market
Market size, share, segmentation and regional forecast.
$707M market · 2025 base year
View reportNon-Invasive Skin Closure Device Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportNon-invasive Shaping Equipment Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.